{
    "Trade/Device Name(s)": [
        "Phenytoin",
        "TDM Calibration set B"
    ],
    "Submitter Information": "Thermo Fisher Scientific Oy",
    "510(k) Number": "K063145",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIP",
        "DKB"
    ],
    "Summary Letter Date": "September 25, 2007",
    "Summary Letter Received Date": "September 27, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3350"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin test system"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Phenytoin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "T60",
        "DPC T60i",
        "DPC T60i Kusti"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Recombinant DNA technology"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Thermo Fisher Scientific Oy Phenytoin assay and TDM Calibration set B for quantitative determination of phenytoin in human serum using T60 analyzers",
    "Indications for Use Summary": "For quantitative in vitro diagnostic determination of phenytoin concentration in human serum using T60 Clinical Chemistry Analyzers; measurements are used in diagnosis and treatment of phenytoin overdose and monitoring therapy; TDM Calibration set B is for use as a calibrator in the phenytoin assay",
    "fda_folder": "Toxicology"
}